is trulicity a glp-1 receptor agonists Semaglutide vs. Other GI Adverse Effects of Glucagon-Like

Researchers also are finding that GLP-1 drugs help with other health problems, including reducing liver diseases

Prior to this several other anti-obesity drugs had also proven disappointing due to adverse effects such as cardiovascular problems, increased suicidal risk and enhanced drug dependence and abuse (Mller, Blher, Tschp, DiMarchi)

In addition, many of these patients will have additional risk factors for delayed gastric emptying (for example, diabetes or obesity) which must be taken into consideration

The "Fuss" About GLP-1 Receptor Agonists The excitement surrounding GLP-1 receptor agonists stems from their effectiveness in not just managing blood sugar but also offering additional health benefits like weight loss and cardiovascular protection

GLP-1 (glucagon-like peptide-1) helps regulate blood sugar, reduce appetite, and increase feelings of fullness, making it easier for patients to manage their weight